More in-depth and systematic studies on the pleiotropic and context-dependent role played by the IGF1/IGF1R pathway in modulating immunity with regards to specific tumor types will also help in defining, in a near future, the best IGF1R inhibitor/immuno-oncotherapeutic combination strategies to treat and ultimately cure cancer patients. Here, IGF1 is linked to cancer.